World Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $3.39M | Sell |
48,547
-579
| -1% | -$40.7K | 0.34% | 59 |
|
|
2021
Q2 | $3.38M | Buy |
49,126
+636
| +1% | +$42.5K | 0.31% | 70 |
|
|
2021
Q1 | $3.08M | Sell |
48,490
-1,293
| -3% | -$83.4K | 0.28% | 76 |
|
|
2020
Q4 | $2.9M | Sell |
49,783
-3,545
| -7% | -$214K | 0.28% | 74 |
|
|
2020
Q3 | $3.37M | Sell |
53,328
-1,622
| -3% | -$112K | 0.35% | 61 |
|
|
2020
Q2 | $4.23M | Sell |
54,950
-19,291
| -26% | -$1.48M | 0.47% | 41 |
|
|
2020
Q1 | $5.55M | Sell |
74,241
-26,113
| -26% | -$1.8M | 0.49% | 40 |
|
|
2019
Q4 | $6.52M | Buy |
100,354
+2,658
| +3% | +$173K | 0.3% | 65 |
|
|
2019
Q3 | $6.19M | Buy |
97,696
+3,250
| +3% | +$212K | 0.3% | 67 |
|
|
2019
Q2 | $6.38M | Sell |
94,446
-5,772
| -6% | -$380K | 0.31% | 63 |
|
|
2019
Q1 | $6.51M | Buy |
100,218
+11,484
| +13% | +$763K | 0.33% | 63 |
|
|
2018
Q4 | $5.55M | Sell |
88,734
-2,525
| -3% | -$176K | 0.34% | 60 |
|
|
2018
Q3 | $7.05M | Buy |
91,259
+436
| +0.5% | +$32.9K | 0.33% | 57 |
|
|
2018
Q2 | $6.43M | Buy |
90,823
+2,789
| +3% | +$197K | 0.31% | 58 |
|
|
2018
Q1 | $6.64M | Sell |
88,034
-29,709
| -25% | -$2.36M | 0.31% | 58 |
|
|
2017
Q4 | $8.44M | Sell |
117,743
-8,240
| -7% | -$626K | 0.28% | 60 |
|
|
2017
Q3 | $10.2M | Sell |
125,983
-565
| -0.4% | -$43.2K | 0.34% | 51 |
|
|
2017
Q2 | $8.96M | Sell |
126,548
-18,526
| -13% | -$1.23M | 0.31% | 52 |
|
|
2017
Q1 | $9.85M | Buy |
145,074
+22,574
| +18% | +$1.59M | 0.32% | 52 |
|
|
2016
Q4 | $8.77M | Sell |
122,500
-9,448
| -7% | -$702K | 0.33% | 51 |
|
|
2016
Q3 | $10.4M | Buy |
131,948
+1,413
| +1% | +$115K | 0.37% | 47 |
|
|
2016
Q2 | $10.9M | Sell |
130,535
-1,609
| -1% | -$143K | 0.42% | 45 |
|
|
2016
Q1 | $12.1M | Sell |
132,144
-24,534
| -16% | -$2.21M | 0.48% | 37 |
|
|
2015
Q4 | $15.9M | Buy |
156,678
+3,210
| +2% | +$334K | 0.6% | 27 |
|
|
2015
Q3 | $15.1M | Buy |
153,468
+1,823
| +1% | +$202K | 0.62% | 26 |
|
|
2015
Q2 | $17.8M | Sell |
151,645
-20,099
| -12% | -$2.2M | 0.7% | 18 |
|
|
2015
Q1 | $16.9M | Sell |
171,744
-3,482
| -2% | -$354K | 0.58% | 26 |
|
|
2014
Q4 | $16.5M | Sell |
175,226
-38,526
| -18% | -$3.98M | 0.56% | 30 |
|
|
2014
Q3 | $22.8M | Buy |
213,752
+8,818
| +4% | +$863K | 0.68% | 21 |
|
|
2014
Q2 | $17M | Sell |
204,934
-1,044
| -0.5% | -$81.3K | 0.52% | 30 |
|
|
2014
Q1 | $14.6M | Sell |
205,978
-27,210
| -12% | -$2.13M | 0.46% | 33 |
|
|
2013
Q4 | $17.5M | Sell |
233,188
-38,171
| -14% | -$2.66M | 0.48% | 33 |
|
|
2013
Q3 | $17.1M | Sell |
271,359
-32,340
| -11% | -$1.93M | 0.43% | 40 |
|
|
2013
Q2 | $15.6M | Buy |
+303,699
| New | +$15.8M | 0.36% | 40 |
|
Other funds holding GILD
World Asset Management's GILD Position: Q3 2021 in Review
World Asset Management reduced its Gilead Sciences (GILD) stake by 1.2% in Q3 2021, selling an estimated $40.7K and leaving 48,547 shares worth $3.39M. The position accounts for 0.34% of the portfolio, ranked #59.
World Asset Management first reported a position in GILD in Q2 2013 and has held it in 34 quarters since. The position peaked at $22.8M in Q3 2014. 1,563 funds tracked by Wall St. Rank hold GILD as of Q3 2021.
- World Asset Management held 48,547 shares of Gilead Sciences worth $3.39M as of Q3 2021.
- World Asset Management sold 579 Gilead Sciences shares in Q3 2021, an estimated $40.7K.
- Gilead Sciences made up 0.34% of World Asset Management's portfolio in Q3 2021, its #59 holding.
- World Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 34 quarters since.
- World Asset Management's Gilead Sciences position peaked at $22.8M in Q3 2014.
- 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2021.
Based on World Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.